Fulgent Genetics Inc.

NASDAQ: FLGT · Real-Time Price · USD
21.38
-0.19 (-0.88%)
At close: Aug 20, 2025, 3:59 PM
21.38
0.00%
After-hours: Aug 20, 2025, 04:10 PM EDT

Fulgent Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
303.22M 292.45M 283.47M 277.76M 290.7M 287.53M 289.21M 286.41M 307.38M 364.87M 618.97M 802.93M 925.15M 953.42M 992.58M 1.04B 909.74M 773.39M
Cost of Revenue
181.82M 180.98M 180.24M 183.1M 182.97M 183.73M 186.72M 194.2M 208.91M 221.7M 252.07M 259.48M 243.39M 219.18M 215.53M 205.17M 187.97M 159.82M
Gross Profit
121.4M 111.47M 103.23M 94.66M 107.73M 103.8M 102.5M 92.21M 98.47M 143.17M 366.9M 543.45M 681.76M 734.24M 777.05M 830.72M 721.77M 613.56M
Operating Income
-72.72M -71.92M -73.92M -208.9M -191.61M -192.5M -195.53M -80.99M -80.85M -48.26M 178.5M 365.94M 524.86M 610.96M 675.95M 751M 655.25M 558.99M
Interest Income
32.49M 32.09M 31.7M 29.33M 27.71M 25.12M 21.27M 20.64M 15.58M 11.44M 7.71M 2.51M 1.6M 1.25M 1.48M 1.97M 1.9M 1.57M
Pretax Income
-59.82M -49.51M -51.96M -189.12M -163.72M -167.21M -174.09M -62.35M -67.45M -39M 184.03M 368.31M 526.32M 612.07M 677.3M 752.97M 657.15M 560.56M
Net Income
-51.02M -40.78M -42.71M -164.97M -163.43M -165.95M -167.82M -63.51M -48.68M -25.92M 143.4M 271.57M 392.38M 460.65M 507.36M 569.33M 493.45M 416.96M
Selling & General & Admin
136.39M 127.63M 124.35M 132.68M 130.26M 129.06M 130.47M 127.31M 135.77M 148.16M 149.99M 141.25M 123.43M 95.88M 75.17M 57.59M 48.03M 39.55M
Research & Development
49.77M 49.78M 48.82M 48.66M 46.89M 43.09M 41.44M 38M 35.49M 32.7M 28.91M 27.86M 26.38M 24.79M 24.22M 21.33M 18.49M 15.02M
Other Expenses
5.97M 3.98M 3.98M -3.89M -3.93M -1.97M n/a 7.9M 7.95M 10.46M 9.39M 8.29M 7.08M 2.61M 1.71M 797K n/a n/a
Operating Expenses
192.13M 181.39M 177.15M 183.33M 179.11M 176.07M 177.79M 173.2M 179.21M 188.42M 185.4M 174.51M 154M 123.28M 101.1M 79.72M 66.52M 54.57M
Interest Expense
255K 238K 232K 22K 78K 78K 70K 304K 234K 234K 279K 80K 576K 576K 531K 496K n/a n/a
Selling & Marketing Expenses
39.41M 35.72M 36.25M 37.21M 38.24M 40.37M 41.47M 41.22M 40.92M 41.06M 38.92M 36.87M 33.02M 27.37M 24.44M 21.32M 20.32M 18.36M
Cost & Expenses
375.94M 364.36M 357.39M 364.47M 360.12M 357.84M 362.55M 367.4M 388.12M 410.12M 437.47M 434M 397.39M 342.46M 316.63M 284.89M 254.49M 214.39M
Income Tax Expense
-7.78M -7.64M -8.14M -17.15M 7.01M 6.03M 1.15M 2.63M -17.28M -11.52M 42.1M 98.64M 135.77M 156.7M 174.79M 186.22M 163.2M 139.01M
Shares Outstanding (Basic)
n/a 30.83M 30.65M 30.42M 30.1M 29.77M 29.77M 30.01M 29.81M 29.54M 29.63M 30.17M 30.36M 30.23M 29.96M 29.67M 29.15M 28.83M
Shares Outstanding (Diluted)
n/a 30.83M 30.65M 30.42M 30.1M 29.77M 29.77M 30.01M 29.81M 29.54M 30.96M 30.87M 31.19M 31.24M 31.2M 31.17M 30.83M 30.77M
EPS (Basic)
-1.04 -1.33 -1.41 -5.52 -5.48 -5.57 -5.64 -2.14 -1.64 -0.88 4.73 9.01 13.08 15.44 17.31 20.38 18.36 15.77
EPS (Diluted)
-1.04 -1.33 -1.41 -5.52 -5.48 -5.57 -5.64 -2.14 -1.64 -0.89 4.56 8.70 12.57 14.79 16.38 19.20 17.25 14.80
EBITDA
-43.78M -41.08M -50.43M -64.84M -40.22M -40.95M -43.76M -46.19M -44.85M -7.33M 212.55M 394.11M 543.2M 620.48M 687.39M 759.64M 661.44M 563.31M
EBIT
-67.89M -65.3M -75.36M -90.11M -64.68M -65.57M -68.59M -74.29M -80.74M -45.26M 181.6M 369M 527.82M 611.63M 676.8M 752.48M 657.15M 560.29M
Depreciation & Amortization
24.09M 24.18M 24.93M 25.27M 25.77M 25.93M 26.14M 29.41M 34.41M 36.45M 34.74M 28.9M 20.65M 14.73M 11.48M 8.63M 6.18M 4.32M